Sylvania Platinum (SLP) Competitors

Dr. Martens (LON:DOCS) and Sylvania Platinum (LON:SLP) are both small-cap consumer cyclical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings.

Which has more volatility and risk, DOCS or SLP?

Dr. Martens has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, Sylvania Platinum has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.

Is DOCS or SLP a better dividend stock?

Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.5%. Sylvania Platinum pays an annual dividend of GBX 2 per share and has a dividend yield of 4.3%. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Sylvania Platinum pays out 93.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens is clearly the better dividend stock, given its higher yield and lower payout ratio.

Is DOCS or SLP more profitable?

Sylvania Platinum has a net margin of 8.55% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Sylvania Platinum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dr. Martens	7.89%	18.91%	8.12%
Sylvania Platinum	8.55%	2.82%	1.69%

Does the MarketBeat Community favor DOCS or SLP?

Sylvania Platinum received 223 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 79.59% of users gave Sylvania Platinum an outperform vote.

Company	Underperform	Outperform
Dr. Martens	Outperform Votes 11 91.67%	Underperform Votes 1 8.33%
Sylvania Platinum	Outperform Votes 234 79.59%	Underperform Votes 60 20.41%

Which has preferable earnings and valuation, DOCS or SLP?

Dr. Martens has higher revenue and earnings than Sylvania Platinum. Dr. Martens is trading at a lower price-to-earnings ratio than Sylvania Platinum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dr. Martens	£874.20M	0.61	£68.97M	£7.05	7.78
Sylvania Platinum	£99.97M	1.49	£8.54M	£2.13	21.68

Does the media refer more to DOCS or SLP?

In the previous week, Dr. Martens and Dr. Martens both had 1 articles in the media. Sylvania Platinum's average media sentiment score of 0.75 beat Dr. Martens' score of -0.01 indicating that Sylvania Platinum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dr. Martens	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sylvania Platinum	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of DOCS or SLP?

69.5% of Dr. Martens shares are held by institutional investors. Comparatively, 17.8% of Sylvania Platinum shares are held by institutional investors. 4.4% of Dr. Martens shares are held by company insiders. Comparatively, 12.2% of Sylvania Platinum shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Dr. Martens beats Sylvania Platinum on 9 of the 16 factors compared between the two stocks.